the freeze-dried powder of supramolecular hydrogel without
DTT as well as the mPEG-g-SS–PAA and a-CD with the
equivalent concentrations inhibited cell growth in a dose-
dependent manner, and showed equivalent cell viability at the
same equivalent concentrations. In particular, the cell viability
for the freeze-dried powder of supramolecular hydrogel
without DTT was close to 100% for low concentrations of 1.2
and 3.0 mg mLꢀ1. However, when the testing concentration for
the freeze-dried powder of supramolecular hydrogel without
DTT was higher than 90 mg mLꢀ1, the supramolecular hydrogel
without DTT showed the cell viability of less than 10% due to the
severe cytotoxicity of high a-CD concentration.34 The severe
cytotoxicity of high equivalent concentration of a-CD was also
depicted by the results in Fig. 8a. In virtue of infinite diluted
condition in body circulation, such reduction-sensitive supra-
molecular hydrogel might meet the requirement of low cyto-
toxicity as an injectable biomaterial.
References
1 J. Li, Adv. Polym. Sci., 2009, 222, 79–113.
2 F. van de Manakker, T. Vermonden, C. F. van Nostrum and
W. E. Hennink, Biomacromolecules, 2009, 10, 3157–3175.
3 J. Li and X. J. Loh, Adv. Drug Delivery Rev., 2008, 60, 1000–1007.
4 I. I. Abu Hashim, T. Higashi, T. Anno, K. Motoyama, A. E. H. Abd-
Elgawad, M. H. El-Shabouri, T. M. Borg and H. Arima, Int. J.
Pharm., 2010, 392, 83–91.
5 Y. Chen, X. H. Pang and C. M. Dong, Adv. Funct. Mater., 2010, 20,
579–586.
6 X. L. Zhang, J. Huang, P. R. Chang, J. L. Li, Y. M. Chen,
D. X. Wang, J. H. Yu and J. H. Chen, Polymer, 2010, 51, 4398–4407.
7 X. P. Ni, A. Cheng and J. Li, J. Biomed. Mater. Res., Part A, 2009,
88A, 1031–1036.
8 S. P. Zhao, J. Lee and W. Xu, Carbohydr. Res., 2009, 344, 2201–2208.
9 L. X. Ren, L. H. He, T. C. Sun, X. Dong, Y. M. Chen, J. Huang and
C. Wang, Macromol. Biosci., 2009, 9, 902–910.
10 D. Wu, T. Wang, B. Lu, Z. D. Xu, S. X. Cheng, X. J. Jiang,
X. Z. Zhang and R. X. Zhuo, Langmuir, 2008, 24, 10306–10312.
11 X. Li and J. Li, J. Biomed. Mater. Res., Part A, 2008, 86A, 1055–1061.
12 J. Li, X. Li, X. Ni, X. Wang, H. Li and K. W. Leong, Biomaterials,
2006, 27, 4132–4140.
13 J. Li, X. Ni and K. W. Leong, J. Biomed. Mater. Res., Part A, 2003,
65A, 196–202.
4
Conclusions
14 T. Wang, X. J. Jiang, Q. Z. Tang, X. Y. Li, T. Lin, D. Q. Wu,
X. Z. Zhang and E. Okello, Acta Biomater., 2009, 5, 2939–2944.
15 K. L. Liu, J. L. Zhu and J. Li, Soft Matter, 2010, 6, 2300–2311.
16 S. P. Zhao, L. M. Zhang and D. Ma, J. Phys. Chem. B, 2006, 110,
16503–16507.
17 S. P. Zhao, L. M. Zhang and D. Ma, J. Phys. Chem. B, 2006, 110,
12225–12229.
18 J. Li, X. Li, Z. Zhou, X. Ni and K. W. Leong, Macromolecules, 2001,
34, 7236–7237.
19 L. H. He, J. Huang, Y. M. Chen, X. J. Xu and L. P. Liu,
Macromolecules, 2005, 38, 3845–3851.
20 K. M. Huh, Y. W. Cho, H. Chung, I. C. Kwon, S. Y. Jeong, T. Ooya,
W. K. Lee, S. Sasaki and N. Yui, Macromol. Biosci., 2004, 4, 92–99.
21 H. S. Choi, K. Kontani, K. M. Huh, S. Sasaki, T. Ooya, W. K. Lee
and N. Yui, Macromol. Biosci., 2002, 2, 298–303.
22 K. M. Huh, T. Ooya, W. K. Lee, S. Sasaki, I. C. Kwon, S. Y. Jeong
and N. Yui, Macromolecules, 2001, 34, 8657–8662.
23 H. S. Choi, K. Yamamoto, T. Ooya and N. Yui, ChemPhysChem,
2005, 6, 1081–1086.
24 R. X. Yuan and X. T. Shuai, J. Polym. Sci., Part B: Polym. Phys.,
2008, 46, 782–790.
Based on the design of molecular structure, the reduction-
sensitive disulfide bond and the included poly(ethylene glycol)
(PEG) segments were combined together to synthesize [PEG
monomethyl ether]-graft-[disulfide-linked poly(amido amine)]
(mPEG-g-SS–PAA). Moreover, the inclusion of a-cyclodextrin
(a-CD) to PEG segments induced the formation of supramo-
lecular hydrogels. Such supramolecular hydrogels inherited the
shear-thinning character and reduction-sensitivity, and showed
an adjustable sustained drug-release characteristic depending
upon the reduction condition. Fortunately, low loading-level of
reducing agent cannot inhibit the formation of hydrogel, and
provided a possibility of regulating drug release profile in
extracellular milieus and normal tissue. This is the first report on
reduction-sensitive supramolecular hydrogel based on cyclo-
dextrin/polymer inclusion. Consideration of their acceptable
cytotoxicity, such reduction-sensitive supramolecular hydrogels
showed a great potential as an injectable smart biomaterial for
the application of drug controlled-release.
25 F. Meng, W. E. Hennink and Z. Zhong, Biomaterials, 2009, 30, 2180–
2198.
26 H. Yu and D. W. Grainger, Macromolecules, 1994, 27, 4554–4560.
27 C. Lin, C. J. Blaauboer, M. M. Timoneda, M. C. Lok, M. van
Steenbergen, W. E. Hennink, Z. Zhong, J. Feijen and
J. F. J. Engbersen, J. Controlled Release, 2008, 126, 166–174.
28 B. Parrish and T. Emrick, Bioconjugate Chem., 2007, 18, 263–267.
29 C. Hua, S. M. Peng and C. M. Dong, Macromolecules, 2008, 41,
6686–6695.
30 Y. Sun, X. L. Yan, T. M. Yuan, J. Liang, Y. J. Fan, Z. W. Gu and
X. D. Zhang, Biomaterials, 2010, 31, 7124–7131.
31 H. Yu and D. W. Grainger, Macromolecules, 1994, 27, 4554–4560.
32 N. V. Tsarevsky and K. Matyjaszewski, Macromolecules, 2002, 35,
9009–9014.
Acknowledgements
The research work was financially supported by 973 Projects of
Chinese Ministry of Science and Technology (2009CB930300);
Foundation
of
Shanghai
Municipality
Commission
(10410710000, 09540709000); Fundamental Research Funds for
the Central Universities (Self-Determined and Innovative
Research Funds of WUT 2010-II-022); and Open Project of
Chinese Academy of Sciences Key Laboratory of Biological
Effects of Nanomaterials and Nanosafety.
33 H. L. Fan, J. Huang, Y. P. Li, J. H. Yu and J. H. Chen, Polymer, 2010,
51, 5107–5114.
34 J. C. Debouzy, F. Fauvelle, S. Crouzy, L. Girault, Y. Chapron,
€
M. Goschl and A. Gadelle, J. Pharm. Sci., 1998, 87, 59–66.
7394 | Soft Matter, 2011, 7, 7386–7394
This journal is ª The Royal Society of Chemistry 2011